Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-112185
Filing Date
2020-04-20
Accepted
2020-04-20 16:23:05
Documents
7
Effectiveness Date
2020-04-20

Document Format Files

Seq Description Document Type Size
1 DEFA14A d843491ddefa14a.htm DEFA14A 67578
2 GRAPHIC g843491img001_v1.jpg GRAPHIC 2374
3 GRAPHIC g843491img002_v1.jpg GRAPHIC 672
4 GRAPHIC g843491img003_v1.jpg GRAPHIC 1535
5 GRAPHIC g843491img004_v1.jpg GRAPHIC 856
6 GRAPHIC g843491img005_v1.jpg GRAPHIC 866
7 GRAPHIC g843491img006_v1.jpg GRAPHIC 864
  Complete submission text file 0001193125-20-112185.txt   79528
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19311 | Film No.: 20802783
SIC: 2836 Biological Products, (No Diagnostic Substances)